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Abstract
Cationic and highly branched poly (trimethylphosphonium ethylacrylate-co-poly (ethylene
glycol) acrylate) (p (TMPEA-co-PEGA)), and its ammonium equivalent, have been synthe-
sised from post-polymerisation modiﬁcation of a poly (bromo ethylacrylate-co-poly (ethyl-
ene glycol) acrylate) (p (BEA-co-PEGA)) precursor polymer produced using reversible
addition fragmentation chain transfer (RAFT) polymerisation. The cationic polymers were
evaluated for their ability to complex nucleic acids, their in vitro cytotoxicity and their
GFP pDNA transfection efﬁciency. The results show RAFT copolymerisation of BEA and
PEGA is a simple route to polyphosphoniums showing reduced cytotoxicities and higher
transfection efﬁciencies than their polyammonium alternatives.
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Introduction
The development of polymeric materials for non-viral
gene delivery applications has become a proliﬁc area
of research over the last two decades.(Whitehead
et al., 2009) These compounds facilitate the use of
nucleic acids such as siRNA, mRNA, and plasmid DNA
as therapeutics to treat a range of diseases with cur-
rently limited traditional small molecule therapeutic
options.(Fire et al., 1998) Historically, non-viral gene
delivery polymers have been cationic polymers or lipids
that can compact negatively charged nucleotides to
form nanoparticle polyplexes, which can be uptaken
by cells. Commonly utilised systems include
polyethyleneimine (PEI), chitosan, polylysine (PLL),
and poly (dimethylamino ethylmethacrylate)
(pDMAEMA).(Cook et al., 2018; Kanasty et al., 2013;
Yin et al., 2014) The vast majority of polymer based
nucleic acid delivery systems rely on amine-based cat-
ionic moieties to complex the phosphate groups of the
desired polynucleotides. Although polyamines and
polyammoniums show good ability to complex nucleo-
tides, they also have signiﬁcant cytotoxic effects aris-
ing either immediately from the free cationic amine
polymer or as a delayed toxicity associated with the in-
tracellular processing of polyplexes.(Godbey et al.,
1999; Godbey et al., 2001; Lv et al., 2006; Wolfert
et al., 1999)
A number of strategies have been used to circumvent
or alter the cytotoxicity of polyamine non-viral vectors,
most of which include variation of the amine pKa or in-
troduction of PEG units.(Pack et al., 2005) Using a
cationic heterocycle, for example pyridinium or
imidazolium, was shown to result in a better dispersion
of the positive charge over the ring and a decreased
toxicity.(Ilies et al., 2003) However, the use of non-
nitrogen centred cations for nucleic acid complexation
has yet to be thoroughly explored.(Rose et al., 2017)
Phosphonium containing compounds are generally less
toxic than their ammonium equivalents due to differ-
ences in ionic radius and charge distribution.(Rose
et al., 2017; Stekar et al., 1995; Strasak et al., 2017)
In addition, phosphonium based lipids have been shown
to transfect cells with high efﬁcacies and lower toxicity
than ammonium analogues.(Guenin et al., 2000)
Interestingly, the few polymeric phosphonium materials
reported so far in the literature showed a similar
trend in relation to toxicity.(Hemp et al., 2012; Hemp
et al., 2012; Ornelas-Megiatto et al., 2012; Rose
et al., 2015) Yet, this was only studied in the case of
linear polymers.
The phosphonium containing polymers investigated
as delivery vectors to date, show good transfection ca-
pabilities with lower toxicities, however the monomers
used are either styrene based or required multistep
syntheses and puriﬁcation. The group of Long,(Hemp,
Allen, et al., 2012; Hemp, Smith, et al., 2012) con-
ducted research involving phosphonium containing
monomers for nucleic acid complexation using modiﬁed
styrene monomers, which can be difﬁcult to polymer-
ise, often require high temperatures and high initiator
concentrations. Fréchet and coworkers, (Ornelas-
Megiatto et al., 2012) and also Rose et al.,(Rose
et al., 2015) synthesised phosphonium containing
monomers with triethylene glycol spacers between
the (meth) acrylate group and the phosphonium moie-
ties. While these monomers showed excellent promise
for gene delivery applications, they typically require
multistep syntheses and puriﬁcation. Poly (bromo
ethylacrylate) (pBEA) has recently been shown to be
an excellent reactive precursor material for post poly-
merisation modiﬁcation with a variety of functionali-
ties, including phosphonium moeities.(Barlow et al.,
2016) The monomer is compatible with controlled
radical polymerisation techniques such as Reversible
Addition Fragmentation chain Transfer (RAFT) polymer-
isation, which enable great control of molecular weight
as well as access to complex architectures.(Boyer
et al., 2009; Cobo et al., 2015) In addition, RAFT poly-
merisation with divinyl comonomers allows simple
access to branched architectures,(Liu et al., 2005a)
which have been shown to be more efﬁcient gene deliv-
ery vectors than linear polymers.(Ahmed & Narain,
2013; Anderson et al., 2005; Wightman et al., 2001) In
this contribution, we report the facile synthesis of
branched phosphonium containing polymers using RAFT
and a post-polymerisation modiﬁcation strategy. The
highly branched p (TMPEA-co-PEGA), and its ammonium
equivalent, were investigated for their ability to com-
plex DNA, toxicity of the polymers, and their potential
to transfect cells in vitro with GFP plasmid DNA.
Experimental
Materials
Poly (ethylene glycol) methyl ether acrylate with aver-
age Mn = 480 (PEGA), di (ethylene glycol) diacrylate
(DEGDA), 4,40-azobis(4-cyanovaleric acid) (ACVA),
trimethylamine solution (31–35 wt. % in ethanol
4.2 M), trimethylphosphine solution (1.0 M in THF),
polyethylenimine branched (bPEI, Mw ~25,000 by LS,
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Mn ~10,000 by SEC), agarose, ethidium bromide solu-
tion (500 μg/mL in H2O), deoxyribonucleic acid (DNA,
low molecular weight from salmon sperm), were all ob-
tained from Sigma-Aldrich. All other materials were
purchased from Fisher Scientiﬁc. Green ﬂuorescent
protein (GFP) expressing plasmid DNA (pWPI) Addgene
plasmid #12254. Bromoethyl acrylate was synthesised
according to a previously published procedure.(Barlow
et al., 2016) The chain transfer agent (CTA),
2-(((Butylthio)-carbonothioyl)thio) propanoic acid
(PABTC) was prepared according to a previously re-
ported procedure.(Ferguson et al., 2005) 50X Tris-
Acetate-EDTA (TAE) buffer for gel electrophoresis was
made up at concentration of 2.0 M Tris acetate (Sigma
Aldrich) and 0.05 M EDTA (Sigma Aldrich) in deionised
water, pH 8.2–8.4, and stored at room temperature.
Agarose loading buffer for samples (colourless) was
made up at 30% (vol/vol) glycerol (Sigma Aldrich) in
deionised water, and stored at room temperature.
2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazo-
lium-5-carboxanilide inner salt (XTT sodium salt), and
Phenazine methosulfate (PMS) were obtained from
Sigma-Aldrich.
Characterisation
Size Exclusion Chromatography (SEC) was performed in
DMF, using an Agilent 390-LC MDS instrument equipped
with differential refractive index (DRI), viscometry,
dual angle light scattering, and dual wavelength UV de-
tectors. The system was equipped with 2 x PLgel Mixed
D columns (300 x 7.5 mm) and a PLgel 5 μm guard col-
umn. The eluent was DMF with 5 mmol NH4BF4 additive,
and samples were run at 1 mL/min at 50 °C. Analyte
samples were ﬁltered through a nylon membrane with
0.22 μm pore size before injection. Apparent molar
mass values (Mn,SEC and Mw,SEC) and dispersity (Đ) of
synthesized polymers were determined by DRI detector
and conventional calibration using Agilent SEC soft-
ware. Poly (methyl methacrylate) (PMMA) standards
(Agilent EasyVials) were used for calibration. The
Kuhn-Mark-Houwink-Sakurada parameter α, relating to
polymer conformation in solution was determined from
the gradient of the double logarithmic plot of intrinsic
viscosity as a function of molecular weight, using the
SEC viscometry detector and Agilent SEC software. Pro-
ton nuclear magnetic resonance spectra (1H NMR) were
recorded on a Bruker Advance 400 or 300 spectrometer
(400 MHz or 300 MHz) at 27 °C, with chemical shift
values (δ) reported in ppm, and the residual proton
signal of the solvent used as internal standard.
Proton-decoupled carbon nuclear magnetic resonance
spectra (13C NMR) were recorded on a Bruker Advance
400 (100 MHz) at 27 °C in CDCl3, with chemical shift
values (δ) reported in ppm, and the residual proton sig-
nal of the solvent used as internal standard (δC 77.16).
Phosphorous 31P NMR spectroscopy was performed on a
Bruker Advance 400 (162 MHz) in DMSO-d6, at 27 °C,
with chemical shift values (δ) reported in ppm. Fourier
transform infrared spectra (FTIR) were recorded on a
Bruker Alpha FTIR ATR. Elemental analyses for CHN
were carried out on a CE440 CHN elemental analyser,
and bromine was analysed using classical oxygen ﬂask
methods by Warwick Analytical Service.
Polymer synthesis
For a typical polymerisation, with the conditions [BEA]:
[PEGA]: [DEGDA]: [CTA]: [I] = 40: 10: 2.5: 1: 0.1, CTA
(PABTC, 10.7 mg, 0.0447 mmol), BEA (0.319 g,
1.78 mmol), PEGA (0.214 g, 0.446 mmol), DEGDA
(23.9 mg, 0.112 mmol), ACVA (1.25 mg, 0.00447 mmol),
and dioxane (0.445 mL) were added to a vial
deoxegenated by bubbling with nitrogen and left to stir
in an oil bath at 70 °C. After a predetermined time, the
solution was removed from the oil bath and the polymer
precipitated in diethyl ether (x3), and dried under vac-
uum. Mw = 127,900 g/mol, Ð = 5.4 (DMF SEC, +NH4BF4
additive eluent, DRI detector with PMMA calibration).
1H NMR spectrum (400 MHz, DMSO-d6, δ ppm): 4.34
(m, 2H, -C (O)O-CH2-CH2-Br), 4.12 (m, 2H, -C (O)O-
CH2-CH2-O-), 3.65 (m, 2H, -C (O)O-CH2-CH2-Br), 3.52
(m, 32H, -CH2- (PEG)), 3.24 (s, 3H, (CH2-CH2-O)-
CH3), 2.39–1.54 (m, 3H, backbone), 0.89 (t, 3H, -CH3
(CTA)). 13C NMR spectrum (100 MHz, CDCl3, δ ppm):
173.79 (-C (O)O-), 70.26 (-CH2- (PEG)), 66.82 (-C (O)
O-CH2-), 30.82 (-CH2-Br), 41.23 (backbone tertiary),
21.87 (backbone -CH2-). FTIR νcm1: 2867 (medium,
C-H alkane), 1728 (strong, C=O ester), 1447 (medium,
C-H alkane), 1093 (strong, C-O-C PEG). 569 (weak, C-
Br). Elemental analysis shown in Table S2.
In order to further characterise the branched nature
of the synthesised polymers, two linear p (BEA-co-
PEGA) polymers were synthesised to give a comparison
for the KMHS intrinsic viscosity vs molecular weight
plots, and associated αvalues. The polymerisation con-
ditions were identical to the above branched polymers,
but without DEGDA crosslinker (conditions and
characterisation data can be seen in the supporting
information). Mn = 9,700 g/mol, Ð = 1.12; and
Mn = 16,800 g/mol, Ð = 1.32; (DMF SEC, +NH4BF4
additive eluent, DRI detector with PMMA calibration).
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1H NMR spectrum (400 MHz, DMSO-d6, δ ppm): 4.34 (m,
2H, -C (O)O-CH2-CH2-Br), 4.12 (m, 2H, -C (O)O-CH2-
CH2-O-), 3.65 (m, 2H, -C (O)O-CH2-CH2-Br), 3.52 (m,
32H, -CH2- (PEG)), 3.24 (s, 3H, (CH2-CH2-O)-CH3),
2.39–1.54 (m, 3H, backbone), 0.89 (t, 3H, -CH3 (CTA)).
13C NMR spectrum (100 MHz, CDCl3, δ ppm): 174.90
(-C (O)O-), 70.19 (-CH2- (PEG)), 65.52 (-C (O)O-CH2-),
31.32 (-CH2-Br), 41.28 (backbone tertiary), 22.87
(backbone -CH2-). FTIR νcm1: 2880 (medium, C-H
alkane), 1725 (strong, C=O ester), 1440 (medium, C-H
alkane), 1095 (strong, C-O-C PEG), 576 (weak, C-Br).
Post-polymerisation modiﬁcation
Typical post-polymerization substitution of branched p
(BEA-co-PEGA) with trimethylamine: p (BEA-co-PEGA)
(0.10 g of polymer, 0.447 mmol of BEA units) was
dissolved in 2 mL of DMSO in a small vial with a
stirrer bar, to which was added 2.5 equivalents of
trimethylamine (4.2 M in ethanol, 266 μL, 1.12 mmol)
and stirred for 48 h under a nitrogen atmosphere. Upon
completion, the solution was concentrated by nitrogen
ﬂow, puriﬁed by precipitation into THF, and dried under
vacuum, to give the desired p (TMAEA-co-PEGA). 1H
NMR (400 MHz, DMSO-d6, ppm): δ = 4.53 (m, 2H, -C
(O)O-CH2-CH2-NMe3), 4.12 (m, 2H, -C (O)O-CH2-CH2-
O-), 3.91 (m, 2H, -C (O)O-CH2-CH2-NMe3), 3.52 (m,
32H, -CH2- (PEG)), 3.34 (m, 9H, CH2-CH2-NMe3), 3.24
(s, 3H, (CH2-CH2-O)-CH3), 2.41–1.51 (m, 3H, back-
bone), 0.89 (m, 3H, -CH3 (CTA)).
13C NMR spectrum
(100 MHz, CDCl3, δ ppm): 174.04 (-C (O)O-), 70.22
(-CH2- (PEG)), 64.00 (-C (O)O-CH2-CH2-), 58.53 (-C (O)
O-CH2-CH2-), 53.42 (-N (CH3)3), 40.85 (backbone
tertiary), 27.02 (backbone -CH2-). FTIR νcm1: 2871
(medium, C-H alkane), 1728 (strong, C=O ester), 1477
(medium, C-H alkane), 1248 (medium, C-N, amine),
1092 (strong, C-O-C PEG). Elemental analysis shown in
Table S2.
Typical post-polymerization substitution of branched
p (BEA-co-PEGA) with trimethylphosphine: p (BEA-co-
PEGA) (0.10 g of polymer, 0.447 mmol of BEA units)
was disolved in 2 mL of DMSO in a small vial with a
stirrer bar, to which was added 2.5 equiv of
trimethylphosphine (1 M in THF, 1.12 mL, 1.12 mmol)
and stirred for 48 h under a nitrogen atmosphere. Upon
completion, the solution was concentrated by nitrogen
ﬂow, puriﬁed by precipitation into THF, and dried
under vacuum, to give the desired p (TMPEA-co-PEGA).
1H NMR (300 MHz, DMSO-d6, ppm): δ = 4.36 (m, 2H,
-C (O)O-CH2-CH2-PMe3), 4.13 (m, 2H, -C (O)O-CH2-
CH2-O-), 3.51 (m, 32H, -CH2- (PEG)), 3.24 (s, 3H,
(CH2-CH2-O)-CH3), 2.83 (m, 2H, -C (O)O-CH2-CH2-
PMe3), 2.07 (m, 9H, CH2-CH2-PMe3), 2.46–1.44 (m, 3H,
backbone), 1.06 (m, 3H, -CH3 (CTA)).
13C NMR spectrum
(100 MHz, CDCl3, δ ppm): 174.13 (-C (O)O-), 70.23
(-CH2- (PEG)), 60.64 (-C (O)O-CH2-CH2-), 54.87 (-C (O)
O-CH2-CH2-), 40.55 (backbone tertiary), 26.82 (back-
bone -CH2-), 5.30 (-P (CH3)3). FTIR νcm
1: 2897
(medium, C-H alkane), 1728 (strong, C=O ester), 1420
(medium, C-H alkane), 1087 (strong, C-O-C PEG), 971
(strong, P-CH3). Elemental analysis shown in Table S2.
DLS/Zetapotential
Dynamic light scattering measurements were carried of
resulting polymers and polyplexes at various N/P ratios
using a Malvern nanoZS zetasizer instrument (scattering
angle of 173°, 10 mW He-Ne laser). For polyplex forma-
tion: appropriate amount of polymer stock solution and
DNA stock solution were mixed and made up to a total
volume of 1 mL in DI water (ﬁnal concentration of poly-
mer was 1 mg/mL, in all solutions). The resulting solu-
tions were vortexed incubated for 30 minutes at room
temperature and were analysed at 25 °C. Each sample
was run in triplicate and data was acquired using the
software (Malvern Zetasizer) provided. Zeta potential
measurements were carried out on the same DLS sam-
ples at various N/P ratios using the same instrument,
and Malvern disposable folded capillary cell (DTS1070)
cuvettes.
Agarose gel electrophoresis
Agarose gels (1% w/v) were prepared with agarose and
1 × TAE buffer. The solution was cooled on the bench
for 5 minutes and 100 μL of 0.5 μg/mL ethidium bro-
mide solution was added. The mixture was poured into
the casted agarose tray and a comb inserted. The gel
was left to set for a minimum of 30 minutes at room
temperature. The agarose gels were run in 1× TAE
buffer. The ﬁnal gel was visualized under UV illumina-
tion at 365 nm using a UVP benchtop UV transillumina-
tor system. Polyplexes of DNA were prepared at
various N/P ratios. DNA stock solution of 60 μg/mL
was prepared in PBS, and polymer stock solution of
300 μg/mL. For polyplex formation: appropriate
amount of polymer stock solution and DNA stock solu-
tion were mixed and made up to a total volume of
100 μL in PBS (ﬁnal concentration of DNA was
0.030 μg/μL, in all solutions). Polyplexes were vortexed
and incubated at room temperature for 30 minutes.
Prior to loading, 30 μL of loading buffer was added to
each sample and 20 μL of polyplexes were loaded into
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the agarose gel wells. Gel electrophoresis was per-
formed at 100 V for 30 minutes.
Cell culture
3 T3 mouse endothelial cells were cultured in High
Glucose DMEM (Dulbecco’s Modiﬁed Eagle Medium) sup-
plemented with 10% bovine calf serum and 1% of 2 mM
glutamine. HEK293T cells were cultured in DMEM me-
dium supplemented with 10% fetal bovine serum, 1%
of 2 mM glutamine and 1% penicillin/streptomycin.
The cells were grown as adherent monolayers at 310 K
under a 5% CO2 humidiﬁed atmosphere and passaged
at approximately 70–80% conﬂuence.
Cytotoxicity assays
For cell viability evaluation, 3 T3 cells were seeded in a
96 well plate at a density of 1 × 104 cells per well. After
16 hours, the culture medium was replaced by fresh
media containing a series of dilution of the polymers
(2, 0.8, 0.2, 0.08, 0.02 mg/mL), prepared from stock
solutions in media. Following 24 hours incubation, the
medium was removed and replaced with fresh medium.
The cells were incubated with a freshly prepared solu-
tion of XTT (0.2 mg/mL1) and N-methyl
dibenzopyrazine methyl sulfate (250 μM) in medium
for 16 hours. Absorbance of the samples was ﬁnally
measured using a plate reader at 450 nm and 650 nm.
The data presented are representative of a minimum
of two independent experiments where each sample
was measured in triplicate. Errors reported correspond
to the standard deviation of the mean. Two tailed t-
tests were performed assuming equal variance.
Transfection
Polyplex samples were prepared prior to incubation
with the cells, via mixing of plasmid DNA solution (ﬁnal
concentrationDNA = 100 μg/mL) with the appropriate
amount of polymer predissolved in sterile water (N/P
ratio = 20), and left to complex at room temperature
for one hour. HEK293T cells were seeded in a 24 well
plate at a density of 1 × 105 cells per well. After
16 hours, the culture medium was replaced by
Optimem® cell culture media (Thermo Fisher
Scientiﬁc) without fetal bovine serum. After one
hour, the media was replaced by fresh Optimem®
media containing the polyplex solutions (ﬁnal
concentrationDNA = 10 μg/mL), the cells left to incubate
for 4 hours under 5% CO2 humidiﬁed atmosphere, then
the media replaced with fresh culture media containing
fetal bovine serum. Following overnight incubation,
cells were washed with PBS, trypsinised, centrifuged,
re-dispersed in ice-cold PBS and ﬁltered into FACS tubes
for analysis. Intracellular ﬂuorescence was quantiﬁed
using a BD LSR II cytometer (BD Biosciences) at excita-
tion 488 nm and emission 525 nm. The geometric mean
ﬂuorescence was used as the sample value. The data in
presented are representative of two separate experi-
ments where each sample was measured in duplicate
(n = 4). All errors reported correspond to the standard
deviation from the mean. Two tailed t-tests were per-
formed assuming equal variance.
Results and Discussion
RAFT polymerisation was ﬁrst used to synthesise highly
branched structures by our group in 2005,(Liu et al.,
2005a; Liu et al., 2005b; Semsarilar et al., 2010) follow-
ing the considerable work of the Sherrington group,
(Isaure et al., 2004; O’Brien et al., 2000; Slark et al.,
2003) who developed facile and versatile branched
polymeric systems using free radical polymerisation.
Here, we employed the chain transfer agent,
2-(((butylthio)carbonothioyl)thio) propanoic acid
(PABTC) to copolymerise bromoethyl acrylate (BEA)
and poly (ethylene glycol) acrylate (PEGA) with cross-
linker diethyleneglycol diacrylate (DEGDA) to form sol-
uble highly branched polymers in a one-pot methodol-
ogy (Fig. 1a). A molar ratio of 80:20 BEA:PEGA was
chosen, which achieves similar weight ratio (and there-
fore charge to PEG ratio) as previous reports in the lit-
erature,(Ornelas-Megiatto et al., 2012; Rose et al.,
2015) but from a facile copolymerisation strategy and
post-polymerisation modiﬁcation. The RAFT polymeri-
sation was conducted at 70 °C in dioxane, with the con-
ditions [BEA]: [PEGA]: [DEGDA]: [CTA]: [I] = 40: 10: 2.5:
1: 0.1, and reached conversions of >90% in 24 hrs with
no macroscopic gelation. Size exclusion chromatogra-
phy (SEC) showed a broad molecular weight distribution
and high molecular weights (Mw = 127,900 g/mol,
Ð = 5.4) for the resulting polymers, as expected for
highly branched polymeric systems (Fig. 1b). Informa-
tion about the branched nature of these polymers and
their globular conformation in solution can be obtained
from viscometry detection on the SEC system. Figure 1b
shows the Kuhn-Mark-Houwink-Sakurada (KMHS) double
Log plot of intrinsic viscosity against molecular weight.
The gradient of the line (α value) gives information
about the extent of polymer branching by inferring in-
formation about the polymer entanglements in solu-
tion. Linear polymers entangle more than branched
polymers of similar molecular weight, leading to higher
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viscosity values which increase with increasing molecu-
lar weight more than equivalent branched systems. Lin-
ear polymers typically have α values of ~ 0.7. Here,
linear p (BEA-co-PEG) was found to have α = 0.6–0.7
(Fig. S2) while the highly branched p (BEA-co-PEGA) re-
active polymer precursor has an α = 0.35, indicating a
highly branched polymer with a globular conformation.
With the highly branched reactive polymer precursor
in hand, post-polymerisation modiﬁcation with
trimethylamine and trimethylphosphine in
DMSO/ethanol and DMSO/THF solvent mixtures, re-
spectively, was used to form structurally equivalent
polyphosphoniums and polyammoniums. Due to the
highly charged nature of the resulting cationic poly-
mers, puriﬁcation from excess nucleophile could be
achieved by precipitation of the charged polymer in
THF. The lack of solubility in organic solvents of the
resulting polymers, however, presented difﬁculties
with characterisation of the molecular weight distribu-
tion using SEC. Using 1H NMR spectroscopy, substitution
of the BEA alkyl halide with trimethylamine and
trimethylphosphine nucleophiles was shown to proceed
to high degrees of substitution of approximately >95%
(Figs. 2, S4 and S6), which agrees with previously re-
ported results, however it was not possible to be more
precise than this due to the broad nature of the
peaks.(Barlow et al., 2016) Phosphorous (31P) NMR
spectroscopy conﬁrmed the presence of phosphonium
moieties on the puriﬁed polymer (Fig. S8). In addition,
elemental analysis was carried out to conﬁrm the struc-
ture of both precursor BEA copolymer and post-
polymerisation modiﬁed polymers (Table S2). In the
case of p (TMAEA-co-PEGA) appearance of nitrogen con-
ﬁrmed successful substitution. However, the technique
was unable to provide a quantitative assessment of sub-
stitution value, as the generation of highly charged cat-
ionic moieties leads to the bromine anion being
retained in the polymer as a counterion. Electropho-
retic light scattering (zeta-potential) was employed to
determine the charge of branched p (BEA-co-PEGA)
precursor, and substituted polymers. The charge
increases from 3.05 mV for p (BEA-co-PEGA) to
positively charged, p (TMAEA-co-PEGA) = +41.1 mV, p
(TMPEA-co-PEGA) = +40.6 mV, further demonstrating
substitution.
Ability of the synthesised highly branched polymers
to complex DNA was investigated using a combination
of agarose gel electrophoresis, DLS, and zetapotential
measurements. The formation of polyplexes at various
N/P ratios, where N refers to nitrogens in the
polymer/vector and P refers to negatively charged
phosphate groups in the nucleic acid, was tested.
(Felgner et al., 1997) For clarity, the different charge
ratios are referred to as either P+/P for phosphonium
polymers or N+/P quaternary ammonium polymers.
Figure 3a and 3b show the agarose gel retardation as-
says for branched p (TMPEA-co-PEGA) and p (TMAEA-
co-PEGA) respectively, with both polymers showing
complexation of DNA at a charge ratio value of 2.
The overall size and surface charge of formed
polyplexes was then determined using zetapotential
and DLS measurements at various charge ratios (Fig.
3d and 3e). At low P+/P and N+/P ratios, observation
of negatively charged polyplex nanoparticles with sizes
Figure 1. a) Reaction scheme for the RAFT polymerisation of (i) BEA and (ii) PEGAwith (iii) crosslinker DEGDA, and subsequent post-po-
lymerisation modiﬁcation with trimethylamine and trimethylphosphine; b) size exclusion chromatogram of p (BEA-co-PEGA) precursor
polymer from refractive index detector, including KMHS plot of p (BEA-co-PEGA) from viscometry detector (DMF, PMMA calibration,
Mn = 127,900 g/mol, Ð = 5.4, α = 0.35).
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of apporiximately 200 nm demonstrate the incomplete
complexation of the oligonucleotide by both polymers,
as excess of nucleic acid accounts for the negative
charge observed. At a charge ratio of 2, both p
(TMPEA-co-PEGA) and p (TMAEA-co-PEGA) form aggre-
gates with sizes of over 2 μm with approximately neu-
tral overall charges (~ -5 mV from zetapotential). At
higher ratio values, branched polymers complex all
the nucleic acid and form electrostatically stabilised
charged polyplexes with sizes of around 200 nm and a
surface charge of approximately +40 mV. Taken to-
gether, these results show that both p (TMPEA-co-PEGA)
and p (TMAEA-co-PEGA) have very similar ability to
complex nucleic acids.
Figure 2. a) 1H NMR spectra in DMSO-d6 of branched p (BEA-co-PEGA) before and after substitution to form p (TMPEA-co-PEGA), b)
1H
NMR spectra in DMSO-d6 of branched p (BEA-co-PEGA) before and after substitution to form p (TMAEA-co-PEGA).
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Difference in the toxicity and transfection efﬁciency
of phosphonium-containing cationic polymers, as com-
pared to ammonium equivalents, was investigated
next. Acute toxicity of the polymers was assessed
in vitro using 3 T3 ﬁbroblast cell line as model. Cells
were incubated with the polymers (0.5 μg/mL –
2 mg/mL) for 24 hr and viability was assessed using a
typical protocol for the XTT assay (Fig. 4a). At concen-
trations of 5 μg/mL and below, all polymers present cell
viability above 80%. While the control, commercial bPEI
(25 k g/mol) shows signiﬁcant toxicity at concentra-
tions above 50 μg/mL, both p (TMPEA-co-PEGA) and p
(TMAEA-co-PEGA) showed no adverse effects to cell vi-
ability at concentration as high as 0.5 and 0.2 mg/mL,
respectively. The fact that phosphonium polymer is ob-
served to be less toxic than the ammonium-containing
equivalent is in accordance with previous report in the
literature. For example, Stekar et al. ﬁrst reported that
trimethylphosphonium cationic headgroups in
phospholipids had lower cytotoxicity in mouse models
compared to equivalent ammonium choline phospho-
lipids, while the lipids also retained similar antineo-
plastic activity in both in vitro and in vivo induced
carcinoma models.(Stekar et al., 1995) A similar
increase in cell viability was observed for
triethylphosphonium polymers as compared to
triethylammonium polymers, for a range of polymer
concentrations.(Ornelas-Megiatto et al., 2012)
The polymers were subsequently assessed for their
propensity to help deliver plasmid DNA encoding for
green ﬂuorescent protein (GFP) in cells. This was done
by incubating model HEK293T cells with polyplexes, at
a N/P ratio of 20, for 4 h, following which the cells were
allowed to further grow for 16 hours prior to cellular
ﬂuorescence quantiﬁcatino using ﬂow cytometry. The
results, shown in Figure 4b, show that polyplexes of
branched p (TMPEA-co-PEGA) enhance transfection ef-
ﬁciency by a factor of approximately six times as
Figure 3. a) p (TMPEA-co-PEGA) polyplex formation with DNA as characterised by agarose gel electrophoresis at varying P+/P charge ra-
tios; b) p (TMAEA-co-PEGA) polyplex formation with DNA as characterised by agarose gel electrophoresis at varying N+/P charge ratios; c)
structures of repeating units; d) surface charge (zetapotential) and e) size of polyplexes formed with DNA at varying N+/P or P+/P ratios
as measured by dynamic light scattering and electrophoretic light scattering, respectively.
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compared to naked pDNA. Interestingly, the transfec-
tion efﬁciency of branched p (TMAEA-co-PEGA) was
shown to only increase the efﬁciency of naked pDNA
by a factor of 3. Such a higher transfection efﬁciency
for the phosphonium polymer when compared to the
ammonium polymer follows the same trend as previ-
ously reported in the literature.(Ornelas-Megiatto
et al., 2012) Both of the synthesised branched polymers
showed around 20-fold lower transfection compared to
commercial branched PEI. We hypothesise that this is
due to the p (TMPEA-co-PEGA) and p (TMAEA-co-PEGA)
polymers being too hydrophilic, and subsequently being
unable to efﬁciently enter cells via endocytosis – a pro-
cess which typically requires a balance of cationic
charge and hydrophobicity.(Nelson et al., 2013) Hemp
et al. reported a similar trend, where polymers with
Figure 4. a) Cytotoxicity as determined by the percentage of cell viability for 3 T3 ﬁbroblast cells treated with branched p (TMPEA-co-
PEGA), branched p (TMAEA-co-PEGA), and bPEI for 24 hours at 37 °C. b) Transfection efﬁciency as determined by the intracellular
ﬂuorescence in HEK-293 T cells following incubation with polyplexes of GFP-plasmid DNA and branched p (TMPEA-co-PEGA), branched
p (TMAEA-co-PEGA) or commercial 25 k g/mol bPEI (N/P 20) for 4 hours at 37 °C and overnight incubation in polyplex-free media, as
measured by ﬂow cytometry. *p < 0.05, **p < 0.01, ***p < 0.001.
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hydrophobic alkyl moieties attached to phosphonium
cations had higher transfection efﬁciencies
compared to more hydrophilic substituents.(Hemp,
Allen, et al., 2012)
Conclusions
In conclusion, we have demonstrated the facile
synthesis of highly branched cationic poly
(trimethylphosphonium ethylacrylate-co-PEGA) using a
simple post-polymerisation modiﬁcation strategy of a
poly (bromo ethylacrylate-co-PEGA) precursor polymer
produced using RAFT polymerisation. This synthesis
represents a signiﬁcant improvement/simpliﬁcation of
current phosphonium containing polymer synthetic
methods. The phosphonium and ammonium containing
polymers were evaluated for ability to complex nucleic
acids, polymer cytotoxicity, and pDNA transfection.
The results show that phosphonium-bearing polymers
have increased biocompatibility and higher transfec-
tion efﬁciencies when compared to their exact ammo-
nium equivalents. While transfection efﬁciencies were
lower than those observed with commercial bPEI, their
much lower toxicity highlights them as promising alter-
natives for gene delivery applications.
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Table S1. Polymerisation conditions for both branched
and linear BEA PEGA copolymers, including characteri-
sation data from SEC and 1H NMR spectroscopy.
Figure S1. Size exclusion chromatograms of branched
and linear p (BEA-co-PEGA) precursor polymers using
refractive index detection (DMF, PMMA calibration,
Mn = 127,900 g/mol, Ð = 5.4).
Figure S2. KMHS plot of branched and linear p (BEA-co-
PEGA) precursor polymers using viscometry detection in
DMF.
Figure S3. 13C NMR spectrum of branched p (BEA-co-
PEGA) precursor polymer in deuterated DMSO.
Figure S4. 1H NMR in DMSO-d6 of branched p (TMPEA-
co-PEGA).
Figure S5. 13C NMR in DMSO-d6 of branched p (TMPEA-
co-PEGA).
Figure S6. 1H NMR in DMSO-d6 of branched p (TMAEA-
co-PEGA).
Figure S7. 13C NMR in DMSO-d6 of branched p (TMAEA-
co-PEGA).
Figure S8. Phosphorous 31P-NMR spectrum of branched
p (TMPEA-co-PEGA) conﬁrming the presence of phos-
phonium moieties on the puriﬁed polymer.
Table S2. Elemental analysis results for branched BEA
PEGA copolymer, branched p (TMPEA-co-PEGA) and p
(TMAEA-co-PEGA).
Figure S9. Proton 1H-NMR spectra of branched p
(TMPEA-co-PEGA) in D2O over 4 weeks at room temper-
ature and pH 7, conﬁrming no hydrolysis of polymer side
chains occurring.
Figure S10. Representative DLS data for polyplex
solutions (branched p (TMPEA-co-PEGA) with DNA, N/P
10, three repeats shown), a) intensity distribution, b)
volume distribution, c) number distribution, d)
correlograms, e) cumulants ﬁt.
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